Who owns Liminatus Pharma Inc A?
- Ticker: LIMN
- CUSIP Number: 53271x108
Tip: Access positions for across all investors
Analyze quarterly positions in Liminatus Pharma Inc A with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Liminatus Pharma Inc A stock
Who bought or sold Liminatus Pharma Inc A this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Cygnus Capital Advisors | 329k | $36k | -6% | Jun 2026 |
|
| XTX Topco | 222k | $25k | 100% | Jun 2026 |
|
| Geode Capital Management | 138k | $15k | 18% | Jun 2026 |
|
| Citadel Advisors | 56k | $6.2k | -92% | Jun 2026 |
|
| Vanguard Capital Management | 50k | $5.5k | 0% | Jun 2026 |
|
| Goldman Sachs Group | 40k | $4.4k | 100% | Jun 2026 |
|
| Intl Fcstone | 26k | $3.9k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 23k | $2.5k | 0% | Jun 2026 |
|
| State Street Corporation | 19k | $3.3k | 0% | Mar 2026 |
|
| UBS Group | 17k | $1.8k | -69% | Jun 2026 |
|
| JustInvest | 13k | $1.5k | -62% | Jun 2026 |
|
| Tower Research Capital | 7.1k | $783.067200 | -6% | Jun 2026 |
|
| Citigroup | 6.8k | $1.2k | 100% | Mar 2026 |
|
| Barclays | 4.3k | $474.045000 | 100% | Jun 2026 |
|
| BlackRock | 313.00 | $34.993400 | -98% | Jun 2026 |
|
Who sold out of Liminatus Pharma Inc A?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Mar 2026 | 71k | $12k |
| Virtu Financial | Mar 2026 | 28k | $5.0k |
| Two Sigma Securities | Mar 2026 | 22k | $3.8k |